BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27093343)

  • 1. Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response.
    Capistrano R; Vangestel C; Wouters A; Dockx Y; Pauwels P; Stroobants S; Apers S; Lardon F; Pieters L; Staelens S
    Cancer Biother Radiopharm; 2016 Apr; 31(3):99-109. PubMed ID: 27093343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model.
    Capistrano I R; Vangestel C; Vanpachtenbeke H; Fransen E; Staelens S; Apers S; Pieters L
    Phytomedicine; 2016 Nov; 23(12):1434-1440. PubMed ID: 27765363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.
    Shah N; Zhai G; Knowles JA; Stockard CR; Grizzle WE; Fineberg N; Zhou T; Zinn KR; Rosenthal EL; Kim H
    Mol Imaging Biol; 2012 Apr; 14(2):237-44. PubMed ID: 21494920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of gemcitabine on the uptake of (18)F-fluorodeoxyglucose and (18)F-fluorothymidine in lung adenocarcinoma A549 cells and the animal tumor model.
    Zhang B; Deng SM; Guo LC; Dong JJ; Zhu YB; Gao Y; Wang ZX; Cho WC
    J Cancer Res Ther; 2016; 12(1):271-6. PubMed ID: 27072250
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Korn RL; Von Hoff DD; Borad MJ; Renschler MF; McGovern D; Curtis Bay R; Ramanathan RK
    Cancer Imaging; 2017 Aug; 17(1):23. PubMed ID: 28774338
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Knight JC; Mosley MJ; Bravo LC; Kersemans V; Allen PD; Mukherjee S; O'Neill E; Cornelissen B
    Clin Cancer Res; 2017 Nov; 23(21):6498-6504. PubMed ID: 28774899
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
    Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
    Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer.
    Xi Y; Yuan P; Li T; Zhang M; Liu MF; Li B
    Cancer Lett; 2020 Jun; 479():112-122. PubMed ID: 32200037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
    Li P; Liu Q; Wang X; Huang G; Song S
    Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Seeds of Colchicum speciosum and Gloriosa superba in respect to Colchicine and Colchicoside Contents by RP-LC.
    Gumustas M; Polat DÇ; Kiliç CS; Akalin K; Ozkan SA; Coşkun M
    Nat Prod Commun; 2016 Mar; 11(3):397-400. PubMed ID: 27169190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Dyall J; Johnson RF; Chefer S; Leyson C; Thomasson D; Seidel J; Ragland DR; Byrum R; Jett C; Cann JA; St Claire M; Jagoda E; Reba RC; Hammoud D; Blaney JE; Jahrling PB
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
    Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts.
    Jensen MM; Erichsen KD; Johnbeck CB; Björkling F; Madsen J; Bzorek M; Jensen PB; Højgaard L; Sehested M; Kjær A
    PLoS One; 2013; 8(1):e53410. PubMed ID: 23308217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Gemcitabine Delivery by
    Russell J; Grkovski M; O'Donoghue IJ; Kalidindi TM; Pillarsetty N; Burnazi EM; Kulick A; Bahr A; Chang Q; LeKaye HC; de Stanchina E; Yu KH; Humm JL
    J Nucl Med; 2021 Feb; 62(2):195-200. PubMed ID: 32646874
    [No Abstract]   [Full Text] [Related]  

  • 18. Intra-tumor metabolic heterogeneity of gastric cancer on
    Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H
    Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y; Wu X; Zhou Y; Jiang H; Pan S; Sun B
    Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.